Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-043849
Filing Date
2025-03-24
Accepted
2025-03-24 16:15:37
Documents
1
Period of Report
2025-03-20

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3290
  Complete submission text file 0000950170-25-043849.txt   4696
Mailing Address 43 THORNDIKE STREET CAMBRIDGE MA 02141
Business Address 43 THORNDIKE STREET CAMBRIDGE MA 02141 617-683-0917
Amylyx Pharmaceuticals, Inc. (Issuer) CIK: 0001658551 (see all company filings)

EIN.: 464600503 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address ENTRADA THERAPEUTICS, INC. 6 TIDE STREET BOSTON MA 02210
Business Address
Zeiher Bernhardt G (Reporting) CIK: 0001971421 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41199 | Film No.: 25764349